Pheochromocytoma is characterized by catecholamine-mediated myocarditis, focal and diffuse myocardial fibrosis, and myocardial dysfunction

Journal of the American College of Cardiology

Volumn 67, Issue 20, 2016, Pages 2364-2374

  Ferreira, Vanessa M ^a   Marcelino, Mafalda ^a   Piechnik, Stefan K ^a   Marini, Claudia ^a   Karamitsos, Theodoros D ^a   Ntusi, Ntobeko A B ^a   Francis, Jane M ^a   Robson, Matthew D ^a   Arnold, J Ranjit ^a   Mihai, Radu ^b   Thomas, Julia D J ^c   Herincs, Maria ^c   Hassan Smith, Zaki K ^d,e   Greiser, Andreas ^f   Arlt, Wiebke ^d,e   Korbonits, Márta ^c   Karavitaki, Niki ^a,d,e   Grossman, Ashley B ^a   Wass, John A H ^a   Neubauer, Stefan ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^d UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^e NHS Foundation Trust   (United Kingdom)

^f SIEMENS AG   (Germany)

Author keywords

cardiac magnetic resonance; catecholamine toxicity; T1 mapping

Indexed keywords

CATECHOLAMINE;

ADULT; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIASTOLIC DYSFUNCTION; DIASTOLIC STRAIN RATE; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE FIBROSIS; HEMODYNAMIC PARAMETERS; HUMAN; HYPERTENSION; LEFT VENTRICULAR MASS INDEX; MAJOR CLINICAL STUDY; MALE; MYOCARDIAL DISEASE; MYOCARDIAL T1; MYOCARDITIS; NUCLEAR MAGNETIC RESONANCE SCANNER; PEAK SYSTOLIC CIRCUMFERENTIAL STRAIN; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; SYSTOLIC DYSFUNCTION; ADRENAL GLAND NEOPLASMS; CARDIAC MUSCLE; CASE CONTROL STUDY; CINE MAGNETIC RESONANCE IMAGING; COMPLICATION; DIAGNOSTIC IMAGING; DIASTOLE; FIBROSIS; HEART; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; METABOLISM; MIDDLE AGED; PATHOLOGY; PERICARDIAL EFFUSION; PROSPECTIVE STUDY; SYSTOLE;

ADRENAL GLAND NEOPLASMS; CASE-CONTROL STUDIES; CATECHOLAMINES; DIASTOLE; FEMALE; FIBROSIS; HEART; HUMANS; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; MYOCARDITIS; MYOCARDIUM; PERICARDIAL EFFUSION; PHEOCHROMOCYTOMA; PROSPECTIVE STUDIES; STROKE VOLUME; SYSTOLE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84968649951     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2016.03.543     Document Type: Article

References (37)

1. A. Prejbisz, J.W.M. Lenders, G. Eisenhofer, and A. Januszewicz Cardiovascular manifestations of phaeochromocytoma J Hypertens 29 2011 2049 2060
2. J.W. Lenders, G. Eisenhofer, M. Mannelli, and K. Pacak Phaeochromocytoma Lancet 366 2005 665 675
3. C.M. Beard, S.G. Sheps, L.T. Kurland, J.A. Carney, and J.T. Lie Occurrence of pheochromocytoma in Rochester, Minnesota, 1950 through 1979 Mayo Clin Proc 58 1983 802 804
4. T. Zelinka, O. Petrák, H. Turková, and et al. high incidence of cardiovascular complications in pheochromocytoma Horm Metab Res 44 2012 379 384
5. R. Yu, N. Nissen, and S. Bannykh Cardiac complications as initial manifestation of pheochromocytoma: frequency, outcome, and predictors Endocr Pract 18 2012 483 492
6. F. Galetta, F. Franzoni, G. Bernini, and et al. Cardiovascular complications in patients with pheochromocytoma: a mini-review Biomed Pharmacother 64 2010 505 509
7. J.-H. Park, K.S. Kim, J.-Y. Sul, and et al. Prevalence and patterns of left ventricular dysfunction in patients with pheochromocytoma J Cardiovasc Ultrasound 19 2011 76 82
8. E.F. Edmondson, J.M. Bright, C.H. Halsey, and E.J. Ehrhart Pathologic and cardiovascular characterization of pheochromocytoma-associated cardiomyopathy in dogs Vet Pathol 52 2015 338 343
9. W. Zierhut, and H.G. Zimmer Significance of myocardial alpha- and beta-adrenoceptors in catecholamine-induced cardiac hypertrophy Circ Res 65 1989 1417 1425
10. R.F. Stolk, C. Bakx, J. Mulder, and et al. Is the excess cardiovascular morbidity in pheochromocytoma related to blood pressure or to catecholamines? J Clin Endocrinol Metab 98 2013 1100 1106
11. T. Kassim, D. Clarke, V. Mai, P. Clyde, and K.M. Shakir Catecholamine-induced cardiomyopathy Endocr Pract 14 2008 1137 1149
12. G.L. Todd, G. Baroldi, G.M. Pieper, and et al. Experimental catecholamine-induced myocardial necrosis I. Morphology, quantification and regional distribution of acute contraction band lesions J Mol Cell Cardiol 17 1985 317 338
13. D.L. Mann, R.L. Kent, B. Parsons, and G. Cooper 4th Adrenergic effects on the biology of the adult mammalian cardiocyte Circulation 85 1992 790 804
14. P.K. Singal, N. Kapur, K.S. Dhillon, and et al. Role of free radicals in catecholamine-induced cardiomyopathy Can J Physiol Pharmacol 60 1982 1390 1397
15. A. Roghi, P. Pedrotti, A. Milazzo, and et al. Adrenergic myocarditis in pheochromocytoma J Cardiovasc Magn Reson 13 2011 4
16. V. de Miguel, A. Arias, A. Paissan, and et al. Catecholamine-induced myocarditis in pheochromocytoma Circulation 129 2014 1348 1349
17. J. Moon, D. Messroghli, P. Kellman, and et al. Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement J Cardiovasc Magn Reson 15 2013 92
18. V.M. Ferreira, S.K. Piechnik, M.D. Robson, and et al. Myocardial tissue characterization by magnetic resonance imaging: novel applications of T1 and T2 mapping J Thorac Imaging 29 2014 147 154
19. V.M. Ferreira, S.K. Piechnik, E. Dall'Armellina, and et al. T1 mapping for the diagnosis of acute myocarditis using CMR: comparison to T2-weighted and late gadolinium enhanced imaging J Am Coll Cardiol Img 6 2013 1048 1058
20. S.K. Piechnik, V.M. Ferreira, E. Dall'Armellina, and et al. Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold J Cardiovasc Magn Reson 12 2010 69
21. V. Ferreira, S. Piechnik, E. Dall'Armellina, and et al. Non-contrast T1-mapping detects acute myocardial edema with high diagnostic accuracy: a comparison to T2-weighted cardiovascular magnetic resonance J Cardiovasc Magn Reson 14 2012 42
22. P.D. Van Vliet, H.B. Burchell, and J.L. Titus Focal myocarditis associated with pheochromocytoma N Engl J Med 274 1966 1102 1108
23. J.E. Szakacs, and B. Mehlman Pathologic changes induced by l-norepineprine: quantitative aspects Am J Cardiol 5 1960 619 627
24. J.E. Szakacs, and A. Cannon L-Norepinephrine myocarditis Am J Clin Pathol 30 1958 425 434
25. R.M. Pearce Experimental myocarditis; a study of the histological changes following intravenous injections of adrenalin J Exp Med 8 1906 400 409
26. I.K. Kline Myocardial alterations associated with pheochromocytomas Am J Pathol 38 1961 539 551
27. S. Bull, S.K. White, S.K. Piechnik, and et al. Human non-contrast T1 values and correlation with histology in diffuse fibrosis Heart 99 2013 932 937
28. N.A.B. Ntusi, S.K. Piechnik, J.M. Francis, and et al. Diffuse myocardial fibrosis and inflammation in rheumatoid arthritis: insights from cardiovascular magnetic resonance T1 mapping J Am Coll Cardiol Img 8 2015 526 536
29. T. Zelinka, K. Pacak, and J. Widimsky Jr. Characteristics of blood pressure in pheochromocytoma Ann N Y Acad Sci 1073 2006 86 93
30. T. Zelinka, B. Strauch, L. Pecen, and J. Widimsky Jr. Diurnal blood pressure variation in pheochromocytoma, primary aldosteronism and Cushing's syndrome J Hum Hypertens 18 2004 107 111
31. M. Kelm, S. Schafer, S. Mingers, and et al. Left ventricular mass is linked to cardiac noradrenaline in normotensive and hypertensive patients J Hypertens 14 1996 1357 1364
32. P. Simpson Norepinephrine-stimulated hypertrophy of cultured rat myocardial cells is an alpha 1 adrenergic response J Clin Invest 72 1983 732 738
33. F.M. Fouad-Tarazi, M. Imamura, E.L. Bravo, and et al. Differences in left ventricular structural and functional changes between pheochromocytoma and essential hypertension. Role of elevated circulating catecholamines Am J Hypertens 5 1992 134 140
34. C. Shub, L. Cueto-Garcia, S.G. Sheps, and et al. Echocardiographic findings in pheochromocytoma Am J Cardiol 57 1986 971 975
35. T. Denolle, G. Chatellier, J. Julien, and et al. Left ventricular mass and geometry before and after etiologic treatment in renovascular hypertension, aldosterone-producing adenoma, and pheochromocytoma Am J Hypertens 6 1993 907 913
36. G. Agarwal, D. Sadacharan, A. Kapoor, and et al. Cardiovascular dysfunction and catecholamine cardiomyopathy in pheochromocytoma patients and their reversal following surgical cure: results of a prospective case-control study Surgery 150 2011 1202 1211
37. F. Galetta, G. Bernini, F. Franzoni, and et al. Preclinical cardiac involvement in phaeochromocytoma: a study with integrated backscatter Clin Endocrinol (Oxf) 68 2008 756 761